PT2155788E

PT2155788E - Aglutinantes duplamente específicos, específicos interespécies

Aglutinantes duplamente específicos, específicos interespécies Download PDF

Info

Publication number: PT2155788E
Authority: PT; Portugal
Prior art keywords: seq; rdc; human; binding; region
Prior art date: 2007-04-03

Application number

PT08735000T

Other languages

English (en)

Portuguese (pt)

Inventor

Peter Kufer

Matthias Klinger

Tobias Raum

Doris Rau

Susanne Mangold

Roman Kischel

Ralf Lutterbuese

Patrick Hoffmann

Original Assignee

Micromet Ag

Priority date

2007-04-03

Filing date

2008-04-03

Publication date

2012-09-25

2008-04-03 Application filed by Micromet Ag filed Critical Micromet Ag

2012-09-25 Publication of PT2155788E publication Critical patent/PT2155788E/pt

Links

239000011230 binding agent Substances 0.000 title description 8
230000027455 binding Effects 0.000 claims description 321
241000282414 Homo sapiens Species 0.000 claims description 253
108090000765 processed proteins & peptides Proteins 0.000 claims description 176
102000004196 processed proteins & peptides Human genes 0.000 claims description 170
229920001184 polypeptide Polymers 0.000 claims description 168
239000013598 vector Substances 0.000 claims description 113
238000000034 method Methods 0.000 claims description 110
230000014509 gene expression Effects 0.000 claims description 71
241000282577 Pan troglodytes Species 0.000 claims description 59
230000008569 process Effects 0.000 claims description 52
102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims description 51
108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims description 51
125000003275 alpha amino acid group Chemical group 0.000 claims description 50
YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims description 49
206010028980 Neoplasm Diseases 0.000 claims description 41
239000008194 pharmaceutical composition Substances 0.000 claims description 30
150000007523 nucleic acids Chemical group 0.000 claims description 24
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 19
201000010099 disease Diseases 0.000 claims description 18
108020004707 nucleic acids Proteins 0.000 claims description 15
102000039446 nucleic acids Human genes 0.000 claims description 15
238000011282 treatment Methods 0.000 claims description 15
101150029707 ERBB2 gene Proteins 0.000 claims description 12
108091028043 Nucleic acid sequence Proteins 0.000 claims description 12
241000288960 Saguinus oedipus Species 0.000 claims description 11
238000004519 manufacturing process Methods 0.000 claims description 11
241000288950 Callithrix jacchus Species 0.000 claims description 10
241000282696 Saimiri sciureus Species 0.000 claims description 8
208000026278 immune system disease Diseases 0.000 claims description 5
230000002062 proliferating effect Effects 0.000 claims description 4
238000012258 culturing Methods 0.000 claims description 3
230000002265 prevention Effects 0.000 claims description 3
QSLPNSWXUQHVLP-FIBGUPNXSA-N trideuterio($l^{1}-sulfanyl)methane Chemical group [2H]C([2H])([2H])[S] QSLPNSWXUQHVLP-FIBGUPNXSA-N 0.000 claims description 3
150000003839 salts Chemical class 0.000 claims 1
102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 375
108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 375
210000004027 cell Anatomy 0.000 description 275
108090000623 proteins and genes Proteins 0.000 description 151
239000012634 fragment Substances 0.000 description 137
241000282693 Cercopithecidae Species 0.000 description 92
102000004169 proteins and genes Human genes 0.000 description 92
235000018102 proteins Nutrition 0.000 description 88
229940024606 amino acid Drugs 0.000 description 76
235000001014 amino acid Nutrition 0.000 description 76
108091007433 antigens Proteins 0.000 description 70
102000036639 antigens Human genes 0.000 description 70
239000000427 antigen Substances 0.000 description 69
210000001744 T-lymphocyte Anatomy 0.000 description 65
150000001413 amino acids Chemical class 0.000 description 65
102100029977 Helicase SKI2W Human genes 0.000 description 59
239000003814 drug Substances 0.000 description 56
241000288906 Primates Species 0.000 description 51
241001465754 Metazoa Species 0.000 description 46
230000015572 biosynthetic process Effects 0.000 description 45
238000003786 synthesis reaction Methods 0.000 description 44
238000003556 assay Methods 0.000 description 43
229940079593 drug Drugs 0.000 description 42
239000002299 complementary DNA Substances 0.000 description 41
101000651021 Homo sapiens Splicing factor, arginine/serine-rich 19 Proteins 0.000 description 40
102100027779 Splicing factor, arginine/serine-rich 19 Human genes 0.000 description 40
239000013612 plasmid Substances 0.000 description 37
235000004279 alanine Nutrition 0.000 description 35
239000000203 mixture Substances 0.000 description 34
108091026890 Coding region Proteins 0.000 description 33
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 33
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 32
241000282553 Macaca Species 0.000 description 30
238000004458 analytical method Methods 0.000 description 30
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 30
239000002953 phosphate buffered saline Substances 0.000 description 30
239000013642 negative control Substances 0.000 description 29
241000282412 Homo Species 0.000 description 28
241000288951 Callithrix <genus> Species 0.000 description 27
241001529936 Murinae Species 0.000 description 27
238000010367 cloning Methods 0.000 description 27
238000002360 preparation method Methods 0.000 description 27
108020001507 fusion proteins Proteins 0.000 description 26
102000037865 fusion proteins Human genes 0.000 description 26
210000004369 blood Anatomy 0.000 description 25
239000008280 blood Substances 0.000 description 25
210000004978 chinese hamster ovary cell Anatomy 0.000 description 25
230000009870 specific binding Effects 0.000 description 25
201000011510 cancer Diseases 0.000 description 23
230000000694 effects Effects 0.000 description 22
101001056234 Homo sapiens Sperm mitochondrial-associated cysteine-rich protein Proteins 0.000 description 21
241000894007 species Species 0.000 description 21
238000001514 detection method Methods 0.000 description 20
239000000243 solution Substances 0.000 description 20
108010022394 Threonine synthase Proteins 0.000 description 19
102000004419 dihydrofolate reductase Human genes 0.000 description 19
238000005259 measurement Methods 0.000 description 19
238000012360 testing method Methods 0.000 description 19
102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 18
108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 18
241000282567 Macaca fascicularis Species 0.000 description 18
239000000872 buffer Substances 0.000 description 18
239000012636 effector Substances 0.000 description 18
239000003550 marker Substances 0.000 description 18
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 17
241000700721 Hepatitis B virus Species 0.000 description 16
108060003951 Immunoglobulin Proteins 0.000 description 16
238000004113 cell culture Methods 0.000 description 16
102000018358 immunoglobulin Human genes 0.000 description 16
108020004414 DNA Proteins 0.000 description 15
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 15
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
150000001875 compounds Chemical class 0.000 description 15
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 14
101710160107 Outer membrane protein A Proteins 0.000 description 14
241000282579 Pan Species 0.000 description 14
230000002950 deficient Effects 0.000 description 14
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 14
239000006228 supernatant Substances 0.000 description 14
241000283707 Capra Species 0.000 description 13
241000588724 Escherichia coli Species 0.000 description 13
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 13
241001123862 Mico Species 0.000 description 13
102100026503 Sperm mitochondrial-associated cysteine-rich protein Human genes 0.000 description 13
230000002411 adverse Effects 0.000 description 13
125000000539 amino acid group Chemical group 0.000 description 13
238000013459 approach Methods 0.000 description 13
210000004899 c-terminal region Anatomy 0.000 description 13
239000012228 culture supernatant Substances 0.000 description 13
229940000406 drug candidate Drugs 0.000 description 13
238000000746 purification Methods 0.000 description 13
238000001890 transfection Methods 0.000 description 13
101000916489 Homo sapiens Chondroitin sulfate proteoglycan 4 Proteins 0.000 description 12
101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 12
101000829725 Homo sapiens Phospholipid hydroperoxide glutathione peroxidase Proteins 0.000 description 12
102000008394 Immunoglobulin Fragments Human genes 0.000 description 12
102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 12
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 12
230000008901 benefit Effects 0.000 description 12
238000001727 in vivo Methods 0.000 description 12
241001515942 marmosets Species 0.000 description 12
125000003729 nucleotide group Chemical group 0.000 description 12
238000002823 phage display Methods 0.000 description 12
101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 description 11
101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 11
108010021625 Immunoglobulin Fragments Proteins 0.000 description 11
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 11
241000282560 Macaca mulatta Species 0.000 description 11
241000700605 Viruses Species 0.000 description 11
102000045108 human EGFR Human genes 0.000 description 11
210000004408 hybridoma Anatomy 0.000 description 11
229960000485 methotrexate Drugs 0.000 description 11
238000010369 molecular cloning Methods 0.000 description 11
239000002773 nucleotide Substances 0.000 description 11
238000012216 screening Methods 0.000 description 11
238000005406 washing Methods 0.000 description 11
108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
239000004471 Glycine Substances 0.000 description 10
125000000729 N-terminal amino-acid group Chemical group 0.000 description 10
239000012980 RPMI-1640 medium Substances 0.000 description 10
241000282695 Saimiri Species 0.000 description 10
230000003013 cytotoxicity Effects 0.000 description 10
231100000135 cytotoxicity Toxicity 0.000 description 10
230000001747 exhibiting effect Effects 0.000 description 10
239000013604 expression vector Substances 0.000 description 10
239000003446 ligand Substances 0.000 description 10
230000035772 mutation Effects 0.000 description 10
210000001519 tissue Anatomy 0.000 description 10
108020004705 Codon Proteins 0.000 description 9
238000002965 ELISA Methods 0.000 description 9
241000530410 Trachypithecus Species 0.000 description 9
239000011324 bead Substances 0.000 description 9
210000000170 cell membrane Anatomy 0.000 description 9
238000006243 chemical reaction Methods 0.000 description 9
239000003795 chemical substances by application Substances 0.000 description 9
238000000684 flow cytometry Methods 0.000 description 9
229930195712 glutamate Natural products 0.000 description 9
229940049906 glutamate Drugs 0.000 description 9
102000049443 human SMCP Human genes 0.000 description 9
230000003993 interaction Effects 0.000 description 9
239000012071 phase Substances 0.000 description 9
229920000136 polysorbate Polymers 0.000 description 9
230000004044 response Effects 0.000 description 9
238000010186 staining Methods 0.000 description 9
238000010561 standard procedure Methods 0.000 description 9
238000002560 therapeutic procedure Methods 0.000 description 9
241000699670 Mus sp. Species 0.000 description 8
241000288935 Platyrrhini Species 0.000 description 8
108010076504 Protein Sorting Signals Proteins 0.000 description 8
229940009098 aspartate Drugs 0.000 description 8
230000004927 fusion Effects 0.000 description 8
210000005260 human cell Anatomy 0.000 description 8
238000000338 in vitro Methods 0.000 description 8
239000002609 medium Substances 0.000 description 8
239000012528 membrane Substances 0.000 description 8
230000002441 reversible effect Effects 0.000 description 8
210000002966 serum Anatomy 0.000 description 8
239000011780 sodium chloride Substances 0.000 description 8
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 7
229920002307 Dextran Polymers 0.000 description 7
102100034349 Integrase Human genes 0.000 description 7
229930182555 Penicillin Natural products 0.000 description 7
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 7
241000282898 Sus scrofa Species 0.000 description 7
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 7
239000004473 Threonine Substances 0.000 description 7
235000009582 asparagine Nutrition 0.000 description 7
229960001230 asparagine Drugs 0.000 description 7
230000004071 biological effect Effects 0.000 description 7
238000005119 centrifugation Methods 0.000 description 7
238000011161 development Methods 0.000 description 7
230000018109 developmental process Effects 0.000 description 7
239000012091 fetal bovine serum Substances 0.000 description 7
230000006870 function Effects 0.000 description 7
239000000499 gel Substances 0.000 description 7
210000003494 hepatocyte Anatomy 0.000 description 7
239000000833 heterodimer Substances 0.000 description 7
230000001965 increasing effect Effects 0.000 description 7
230000000670 limiting effect Effects 0.000 description 7
229940049954 penicillin Drugs 0.000 description 7
239000000047 product Substances 0.000 description 7
230000001105 regulatory effect Effects 0.000 description 7
230000011664 signaling Effects 0.000 description 7
239000007787 solid Substances 0.000 description 7
229960005322 streptomycin Drugs 0.000 description 7
229940124597 therapeutic agent Drugs 0.000 description 7
241000862448 Chlorocebus Species 0.000 description 6
238000012286 ELISA Assay Methods 0.000 description 6
101710091045 Envelope protein Proteins 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
101001073216 Homo sapiens Period circadian protein homolog 2 Proteins 0.000 description 6
241000282559 Macaca sylvanus Species 0.000 description 6
102100035787 Period circadian protein homolog 2 Human genes 0.000 description 6
101710188315 Protein X Proteins 0.000 description 6
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 6
238000010521 absorption reaction Methods 0.000 description 6
229960003669 carbenicillin Drugs 0.000 description 6
239000003153 chemical reaction reagent Substances 0.000 description 6
239000011651 chromium Substances 0.000 description 6
230000008878 coupling Effects 0.000 description 6
238000010168 coupling process Methods 0.000 description 6
238000005859 coupling reaction Methods 0.000 description 6
210000003527 eukaryotic cell Anatomy 0.000 description 6
210000004602 germ cell Anatomy 0.000 description 6
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
238000011534 incubation Methods 0.000 description 6
208000015181 infectious disease Diseases 0.000 description 6
238000002955 isolation Methods 0.000 description 6
229960000310 isoleucine Drugs 0.000 description 6
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 6
239000002777 nucleoside Substances 0.000 description 6
238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 6
230000001225 therapeutic effect Effects 0.000 description 6
210000004881 tumor cell Anatomy 0.000 description 6
108091003079 Bovine Serum Albumin Proteins 0.000 description 5
241000282602 Colobus Species 0.000 description 5
241000196324 Embryophyta Species 0.000 description 5
241000711549 Hepacivirus C Species 0.000 description 5
101000573411 Homo sapiens Vasopressin-neurophysin 2-copeptin Proteins 0.000 description 5
241000713772 Human immunodeficiency virus 1 Species 0.000 description 5
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
241000699666 Mus <mouse, genus> Species 0.000 description 5
108091034117 Oligonucleotide Proteins 0.000 description 5
241001504519 Papio ursinus Species 0.000 description 5
241000367425 Piliocolobus badius Species 0.000 description 5
241000277925 Piliocolobus foai Species 0.000 description 5
102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 5
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 5
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 5
241000283984 Rodentia Species 0.000 description 5
241000566137 Sagittarius Species 0.000 description 5
108091008874 T cell receptors Proteins 0.000 description 5
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 5
230000004913 activation Effects 0.000 description 5
238000012867 alanine scanning Methods 0.000 description 5
230000003321 amplification Effects 0.000 description 5
CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 5
210000003169 central nervous system Anatomy 0.000 description 5
238000002784 cytotoxicity assay Methods 0.000 description 5
231100000263 cytotoxicity test Toxicity 0.000 description 5
230000001419 dependent effect Effects 0.000 description 5
238000009472 formulation Methods 0.000 description 5
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 5
208000002672 hepatitis B Diseases 0.000 description 5
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 5
102000045694 human AVP Human genes 0.000 description 5
102000051957 human ERBB2 Human genes 0.000 description 5
230000003053 immunization Effects 0.000 description 5
238000002649 immunization Methods 0.000 description 5
230000006698 induction Effects 0.000 description 5
230000004048 modification Effects 0.000 description 5
238000012986 modification Methods 0.000 description 5
210000004898 n-terminal fragment Anatomy 0.000 description 5
238000003199 nucleic acid amplification method Methods 0.000 description 5
125000003835 nucleoside group Chemical group 0.000 description 5
239000002245 particle Substances 0.000 description 5
NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 5
102000005962 receptors Human genes 0.000 description 5
108020003175 receptors Proteins 0.000 description 5
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
238000006467 substitution reaction Methods 0.000 description 5
239000000758 substrate Substances 0.000 description 5
230000009261 transgenic effect Effects 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
WOVTUUKKGNHVFZ-UHFFFAOYSA-N 4-(fluoren-9-ylidenemethyl)benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1C=C1C2=CC=CC=C2C2=CC=CC=C21 WOVTUUKKGNHVFZ-UHFFFAOYSA-N 0.000 description 4
102000002260 Alkaline Phosphatase Human genes 0.000 description 4
108020004774 Alkaline Phosphatase Proteins 0.000 description 4
241000894006 Bacteria Species 0.000 description 4
241000282551 Cercopithecus Species 0.000 description 4
241000282533 Colobinae Species 0.000 description 4
101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 description 4
241000282564 Macaca fuscata Species 0.000 description 4
241000282517 Papio cynocephalus Species 0.000 description 4
241000282515 Papio hamadryas Species 0.000 description 4
241001443706 Papio papio Species 0.000 description 4
239000004698 Polyethylene Substances 0.000 description 4
239000002202 Polyethylene glycol Substances 0.000 description 4
241000015710 Semnopithecus Species 0.000 description 4
108010003723 Single-Domain Antibodies Proteins 0.000 description 4
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 4
102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 description 4
CKLJMWTZIZZHCS-REOHCLBHSA-L aspartate group Chemical group N[C@@H](CC(=O)[O-])C(=O)[O-] CKLJMWTZIZZHCS-REOHCLBHSA-L 0.000 description 4
MXWJVTOOROXGIU-UHFFFAOYSA-N atrazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)C)=N1 MXWJVTOOROXGIU-UHFFFAOYSA-N 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 4
229910002091 carbon monoxide Inorganic materials 0.000 description 4
239000000969 carrier Substances 0.000 description 4
230000008859 change Effects 0.000 description 4
238000002648 combination therapy Methods 0.000 description 4
210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 4
230000001472 cytotoxic effect Effects 0.000 description 4
238000009826 distribution Methods 0.000 description 4
239000000839 emulsion Substances 0.000 description 4
239000003623 enhancer Substances 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
230000002349 favourable effect Effects 0.000 description 4
239000012530 fluid Substances 0.000 description 4
WHUUTDBJXJRKMK-VKHMYHEASA-L glutamate group Chemical group N[C@@H](CCC(=O)[O-])C(=O)[O-] WHUUTDBJXJRKMK-VKHMYHEASA-L 0.000 description 4
230000000977 initiatory effect Effects 0.000 description 4
-1 inter alia Proteins 0.000 description 4
125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 4
230000007246 mechanism Effects 0.000 description 4
NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 4
229920001223 polyethylene glycol Polymers 0.000 description 4
108091033319 polynucleotide Proteins 0.000 description 4
239000002157 polynucleotide Substances 0.000 description 4
102000040430 polynucleotide Human genes 0.000 description 4
239000011541 reaction mixture Substances 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
239000012064 sodium phosphate buffer Substances 0.000 description 4
239000007790 solid phase Substances 0.000 description 4
238000013518 transcription Methods 0.000 description 4
230000035897 transcription Effects 0.000 description 4
239000012096 transfection reagent Substances 0.000 description 4
238000012546 transfer Methods 0.000 description 4
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
238000001262 western blot Methods 0.000 description 4
108010088751 Albumins Proteins 0.000 description 3
102000009027 Albumins Human genes 0.000 description 3
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 3
239000002126 C01EB10 - Adenosine Substances 0.000 description 3
241000282690 Cercopithecinae Species 0.000 description 3
241000718131 Cercopithecus kandti Species 0.000 description 3
241001058750 Cercopithecus sclateri Species 0.000 description 3
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
108020004635 Complementary DNA Proteins 0.000 description 3
241000699802 Cricetulus griseus Species 0.000 description 3
108090000695 Cytokines Proteins 0.000 description 3
102000004127 Cytokines Human genes 0.000 description 3
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
101150074155 DHFR gene Proteins 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
241000238631 Hexapoda Species 0.000 description 3
101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 3
229930182816 L-glutamine Natural products 0.000 description 3
241001277090 Lophocebus Species 0.000 description 3
241001277092 Lophocebus albigena Species 0.000 description 3
239000004472 Lysine Substances 0.000 description 3
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
241000282561 Macaca nemestrina Species 0.000 description 3
241000282562 Macaca radiata Species 0.000 description 3
241000124843 Macaca tonkeana Species 0.000 description 3
102000018697 Membrane Proteins Human genes 0.000 description 3
108010052285 Membrane Proteins Proteins 0.000 description 3
241000282520 Papio Species 0.000 description 3
241000282516 Papio anubis Species 0.000 description 3
102000003992 Peroxidases Human genes 0.000 description 3
241000277951 Piliocolobus pennantii Species 0.000 description 3
101710182846 Polyhedrin Proteins 0.000 description 3
229920001213 Polysorbate 20 Polymers 0.000 description 3
241000282604 Presbytis Species 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
239000012979 RPMI medium Substances 0.000 description 3
241000700159 Rattus Species 0.000 description 3
241000288959 Saguinus Species 0.000 description 3
229920002684 Sepharose Polymers 0.000 description 3
241000530413 Trachypithecus vetulus Species 0.000 description 3
108091023040 Transcription factor Proteins 0.000 description 3
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
239000013543 active substance Substances 0.000 description 3
229960005305 adenosine Drugs 0.000 description 3
239000000853 adhesive Substances 0.000 description 3
230000001070 adhesive effect Effects 0.000 description 3
230000009831 antigen interaction Effects 0.000 description 3
230000000890 antigenic effect Effects 0.000 description 3
125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 3
210000003719 b-lymphocyte Anatomy 0.000 description 3
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 3
230000000903 blocking effect Effects 0.000 description 3
239000006143 cell culture medium Substances 0.000 description 3
229910052804 chromium Inorganic materials 0.000 description 3
238000002591 computed tomography Methods 0.000 description 3
238000010276 construction Methods 0.000 description 3
238000004925 denaturation Methods 0.000 description 3
230000036425 denaturation Effects 0.000 description 3
239000008121 dextrose Substances 0.000 description 3
239000000539 dimer Substances 0.000 description 3
238000010494 dissociation reaction Methods 0.000 description 3
230000005593 dissociations Effects 0.000 description 3
238000004520 electroporation Methods 0.000 description 3
230000008030 elimination Effects 0.000 description 3
238000003379 elimination reaction Methods 0.000 description 3
210000002472 endoplasmic reticulum Anatomy 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
238000011156 evaluation Methods 0.000 description 3
238000000605 extraction Methods 0.000 description 3
238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
230000012010 growth Effects 0.000 description 3
239000001963 growth medium Substances 0.000 description 3
238000003306 harvesting Methods 0.000 description 3
230000036541 health Effects 0.000 description 3
238000009396 hybridization Methods 0.000 description 3
239000003999 initiator Substances 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
230000003834 intracellular effect Effects 0.000 description 3
238000001990 intravenous administration Methods 0.000 description 3
239000002502 liposome Substances 0.000 description 3
239000007788 liquid Substances 0.000 description 3
229960003646 lysine Drugs 0.000 description 3
238000012423 maintenance Methods 0.000 description 3
108020004999 messenger RNA Proteins 0.000 description 3
210000000056 organ Anatomy 0.000 description 3
210000001672 ovary Anatomy 0.000 description 3
108040007629 peroxidase activity proteins Proteins 0.000 description 3
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
239000013641 positive control Substances 0.000 description 3
230000003389 potentiating effect Effects 0.000 description 3
210000001236 prokaryotic cell Anatomy 0.000 description 3
230000035755 proliferation Effects 0.000 description 3
239000012460 protein solution Substances 0.000 description 3
230000009257 reactivity Effects 0.000 description 3
238000010188 recombinant method Methods 0.000 description 3
230000010076 replication Effects 0.000 description 3
230000019491 signal transduction Effects 0.000 description 3
230000006641 stabilisation Effects 0.000 description 3
238000011105 stabilization Methods 0.000 description 3
238000007920 subcutaneous administration Methods 0.000 description 3
239000000126 substance Substances 0.000 description 3
239000000725 suspension Substances 0.000 description 3
125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 3
229940104230 thymidine Drugs 0.000 description 3
238000013519 translation Methods 0.000 description 3
239000004474 valine Substances 0.000 description 3
239000003981 vehicle Substances 0.000 description 3
GOODXEAJZGMZKG-UHFFFAOYSA-N 1-hydroxypyrrolidine-2,5-dione;hydrochloride Chemical compound Cl.ON1C(=O)CCC1=O GOODXEAJZGMZKG-UHFFFAOYSA-N 0.000 description 2
QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 2
108700012439 CA9 Proteins 0.000 description 2
102100024423 Carbonic anhydrase 9 Human genes 0.000 description 2
241001123863 Cebuella Species 0.000 description 2
241000282691 Cercocebus Species 0.000 description 2
241001272559 Cercopithecoidea Species 0.000 description 2
241000905614 Cercopithecus campbelli Species 0.000 description 2
241000720696 Cercopithecus denti Species 0.000 description 2
241001504539 Cercopithecus diana Species 0.000 description 2
241000718135 Cercopithecus doggetti Species 0.000 description 2
241000282550 Cercopithecus hamlyni Species 0.000 description 2
241001504548 Cercopithecus mitis Species 0.000 description 2
241001504544 Cercopithecus mona Species 0.000 description 2
241000717099 Cercopithecus roloway Species 0.000 description 2
108010019670 Chimeric Antigen Receptors Proteins 0.000 description 2
208000000419 Chronic Hepatitis B Diseases 0.000 description 2
108020004638 Circular DNA Proteins 0.000 description 2
241001466851 Colobus guereza Species 0.000 description 2
101710139375 Corneodesmosin Proteins 0.000 description 2
102000001301 EGF receptor Human genes 0.000 description 2
241000282554 Erythrocebus Species 0.000 description 2
241000206602 Eukaryota Species 0.000 description 2
101000973901 Homo sapiens Tyrosine-protein kinase Mer Proteins 0.000 description 2
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 2
108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 2
SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
108010002350 Interleukin-2 Proteins 0.000 description 2
UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
241000282566 Macaca arctoides Species 0.000 description 2
241000282521 Macaca assamensis Species 0.000 description 2
241000293886 Macaca maura Species 0.000 description 2
241000532835 Macaca nigra Species 0.000 description 2
241000293895 Macaca ochreata Species 0.000 description 2
241000282522 Macaca sinica Species 0.000 description 2
241000532830 Macaca thibetana Species 0.000 description 2
241000282537 Mandrillus sphinx Species 0.000 description 2
241001448472 Miopithecus ogouensis Species 0.000 description 2
241001504668 Miopithecus talapoin Species 0.000 description 2
241000158423 Nasalis larvatus Species 0.000 description 2
229930193140 Neomycin Natural products 0.000 description 2
102000052812 Ornithine decarboxylases Human genes 0.000 description 2
108700005126 Ornithine decarboxylases Proteins 0.000 description 2
108091000080 Phosphotransferase Proteins 0.000 description 2
108010004729 Phycoerythrin Proteins 0.000 description 2
241000277920 Piliocolobus tephrosceles Species 0.000 description 2
241000276498 Pollachius virens Species 0.000 description 2
RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 2
241000206607 Porphyra umbilicalis Species 0.000 description 2
241000130363 Procolobus verus Species 0.000 description 2
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 2
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 2
241001221333 Pygathrix nigripes Species 0.000 description 2
241000118407 Rhinopithecus Species 0.000 description 2
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
241000027720 Semnopithecus hector Species 0.000 description 2
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
241000966334 Simias Species 0.000 description 2
241000256251 Spodoptera frugiperda Species 0.000 description 2
108010090804 Streptavidin Proteins 0.000 description 2
241000282887 Suidae Species 0.000 description 2
239000012505 Superdex™ Substances 0.000 description 2
208000000389 T-cell leukemia Diseases 0.000 description 2
208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 2
241000375392 Tana Species 0.000 description 2
108010006785 Taq Polymerase Proteins 0.000 description 2
241000282539 Theropithecus gelada Species 0.000 description 2
241000533339 Trachypithecus cristatus Species 0.000 description 2
241000530355 Trachypithecus francoisi Species 0.000 description 2
241000027718 Trachypithecus hatinhensis Species 0.000 description 2
241000931179 Trachypithecus johnii Species 0.000 description 2
241000530356 Trachypithecus obscurus Species 0.000 description 2
241000881893 Trachypithecus phayrei Species 0.000 description 2
241000367439 Trachypithecus pileatus Species 0.000 description 2
102000040945 Transcription factor Human genes 0.000 description 2
241000255985 Trichoplusia Species 0.000 description 2
239000007983 Tris buffer Substances 0.000 description 2
229940127174 UCHT1 Drugs 0.000 description 2
206010046543 Urinary incontinence Diseases 0.000 description 2
108010067390 Viral Proteins Proteins 0.000 description 2
208000036142 Viral infection Diseases 0.000 description 2
238000002835 absorbance Methods 0.000 description 2
239000008351 acetate buffer Substances 0.000 description 2
230000001154 acute effect Effects 0.000 description 2
238000000246 agarose gel electrophoresis Methods 0.000 description 2
125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 2
210000004102 animal cell Anatomy 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 2
150000001540 azides Chemical class 0.000 description 2
230000006399 behavior Effects 0.000 description 2
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
229960002685 biotin Drugs 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
239000011616 biotin Substances 0.000 description 2
238000004820 blood count Methods 0.000 description 2
210000001185 bone marrow Anatomy 0.000 description 2
238000009583 bone marrow aspiration Methods 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
235000014633 carbohydrates Nutrition 0.000 description 2
230000003915 cell function Effects 0.000 description 2
230000007969 cellular immunity Effects 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
239000013522 chelant Substances 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
238000005345 coagulation Methods 0.000 description 2
230000015271 coagulation Effects 0.000 description 2
238000004132 cross linking Methods 0.000 description 2
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
230000009089 cytolysis Effects 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000007423 decrease Effects 0.000 description 2
239000003599 detergent Substances 0.000 description 2
238000010586 diagram Methods 0.000 description 2
238000000502 dialysis Methods 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
239000003937 drug carrier Substances 0.000 description 2
VLCYCQAOQCDTCN-UHFFFAOYSA-N eflornithine Chemical compound NCCCC(N)(C(F)F)C(O)=O VLCYCQAOQCDTCN-UHFFFAOYSA-N 0.000 description 2
210000001723 extracellular space Anatomy 0.000 description 2
238000001641 gel filtration chromatography Methods 0.000 description 2
238000002523 gelfiltration Methods 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
238000010353 genetic engineering Methods 0.000 description 2
230000010224 hepatic metabolism Effects 0.000 description 2
208000006454 hepatitis Diseases 0.000 description 2
238000005734 heterodimerization reaction Methods 0.000 description 2
125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
102000056982 human CD33 Human genes 0.000 description 2
102000045684 human MERTK Human genes 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
238000001597 immobilized metal affinity chromatography Methods 0.000 description 2
210000002865 immune cell Anatomy 0.000 description 2
230000008105 immune reaction Effects 0.000 description 2
230000028993 immune response Effects 0.000 description 2
239000003018 immunosuppressive agent Substances 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
210000003292 kidney cell Anatomy 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
210000004698 lymphocyte Anatomy 0.000 description 2
230000036210 malignancy Effects 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
229940126601 medicinal product Drugs 0.000 description 2
229960004927 neomycin Drugs 0.000 description 2
210000004940 nucleus Anatomy 0.000 description 2
QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 2
210000001322 periplasm Anatomy 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
102000020233 phosphotransferase Human genes 0.000 description 2
229920001993 poloxamer 188 Polymers 0.000 description 2
229920000570 polyether Polymers 0.000 description 2
238000003752 polymerase chain reaction Methods 0.000 description 2
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
229920000053 polysorbate 80 Polymers 0.000 description 2
238000011160 research Methods 0.000 description 2
210000003705 ribosome Anatomy 0.000 description 2
230000028327 secretion Effects 0.000 description 2
230000035939 shock Effects 0.000 description 2
229910052709 silver Inorganic materials 0.000 description 2
239000004332 silver Substances 0.000 description 2
239000011734 sodium Substances 0.000 description 2
125000006850 spacer group Chemical group 0.000 description 2
210000000952 spleen Anatomy 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
210000000130 stem cell Anatomy 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
238000011285 therapeutic regimen Methods 0.000 description 2
238000003325 tomography Methods 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
102000035160 transmembrane proteins Human genes 0.000 description 2
108091005703 transmembrane proteins Proteins 0.000 description 2
239000013638 trimer Substances 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
230000009385 viral infection Effects 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
239000011592 zinc chloride Substances 0.000 description 2
235000005074 zinc chloride Nutrition 0.000 description 2
JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 1
HKZAAJSTFUZYTO-LURJTMIESA-N (2s)-2-[[2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoic acid Chemical group NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O HKZAAJSTFUZYTO-LURJTMIESA-N 0.000 description 1
GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
101150057657 27 gene Proteins 0.000 description 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 1
241000238876 Acari Species 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
101710117290 Aldo-keto reductase family 1 member C4 Proteins 0.000 description 1
241000530393 Allenopithecus Species 0.000 description 1
241000530406 Allenopithecus nigroviridis Species 0.000 description 1
241001326070 Allochrocebus preussi Species 0.000 description 1
241001326056 Allochrocebus solatus Species 0.000 description 1
208000000044 Amnesia Diseases 0.000 description 1
101100183125 Arabidopsis thaliana MBD12 gene Proteins 0.000 description 1
101100067974 Arabidopsis thaliana POP2 gene Proteins 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
241001465318 Aspergillus terreus Species 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
229940122361 Bisphosphonate Drugs 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
208000003174 Brain Neoplasms Diseases 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
108010058905 CD44v6 antigen Proteins 0.000 description 1
101100298998 Caenorhabditis elegans pbs-3 gene Proteins 0.000 description 1
101100352418 Caenorhabditis elegans plp-1 gene Proteins 0.000 description 1
241000601458 Callithrix humilis Species 0.000 description 1
101710132601 Capsid protein Proteins 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
241000282692 Catarrhini Species 0.000 description 1
241000282513 Cebidae Species 0.000 description 1
241001376293 Cercocebus agilis Species 0.000 description 1
241000282556 Cercocebus atys Species 0.000 description 1
241000050066 Cercocebus atys atys Species 0.000 description 1
241001277065 Cercocebus atys lunulatus Species 0.000 description 1
241001277093 Cercocebus chrysogaster Species 0.000 description 1
241000282557 Cercocebus galeritus Species 0.000 description 1
241000282558 Cercocebus torquatus Species 0.000 description 1
241000027672 Cercopithecus albogularis Species 0.000 description 1
241001504542 Cercopithecus ascanius Species 0.000 description 1
241000282549 Cercopithecus cephus Species 0.000 description 1
241000717100 Cercopithecus dryas Species 0.000 description 1
241000413410 Cercopithecus erythrotis Species 0.000 description 1
241001504514 Cercopithecus neglectus Species 0.000 description 1
241001504511 Cercopithecus nictitans Species 0.000 description 1
241001464958 Cercopithecus pogonias Species 0.000 description 1
241000065660 Cercopithecus wolfi Species 0.000 description 1
241000168917 Chiromyiformes Species 0.000 description 1
241001227713 Chiron Species 0.000 description 1
VYZAMTAEIAYCRO-BJUDXGSMSA-N Chromium-51 Chemical compound [51Cr] VYZAMTAEIAYCRO-BJUDXGSMSA-N 0.000 description 1
206010008909 Chronic Hepatitis Diseases 0.000 description 1
241000543381 Cliftonia monophylla Species 0.000 description 1
101710094648 Coat protein Proteins 0.000 description 1
241000530382 Colobus angolensis Species 0.000 description 1
241000282601 Colobus polykomos Species 0.000 description 1
241000730883 Colobus satanas Species 0.000 description 1
241001481822 Colobus sp. Species 0.000 description 1
241000198208 Colobus vellerosus Species 0.000 description 1
206010055114 Colon cancer metastatic Diseases 0.000 description 1
208000001333 Colorectal Neoplasms Diseases 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
108010047041 Complementarity Determining Regions Proteins 0.000 description 1
206010010301 Confusion and disorientation Diseases 0.000 description 1
102100031673 Corneodesmosin Human genes 0.000 description 1
241001417483 Cryptacanthodidae Species 0.000 description 1
241000701022 Cytomegalovirus Species 0.000 description 1
206010011831 Cytomegalovirus infection Diseases 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
241001416561 Daubentoniidae Species 0.000 description 1
206010011968 Decreased immune responsiveness Diseases 0.000 description 1
206010013457 Dissociation Diseases 0.000 description 1
108060006698 EGF receptor Proteins 0.000 description 1
241000758827 Ebenus Species 0.000 description 1
LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
240000000279 Emilia sonchifolia Species 0.000 description 1
235000002139 Emilia sonchifolia Nutrition 0.000 description 1
YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
206010015108 Epstein-Barr virus infection Diseases 0.000 description 1
241001481760 Erethizon dorsatum Species 0.000 description 1
101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 description 1
241001524679 Escherichia virus M13 Species 0.000 description 1
229920001917 Ficoll Polymers 0.000 description 1
241000724791 Filamentous phage Species 0.000 description 1
241000192125 Firmicutes Species 0.000 description 1
101150094690 GAL1 gene Proteins 0.000 description 1
241000122126 Galagidae Species 0.000 description 1
102100028501 Galanin peptides Human genes 0.000 description 1
102000053187 Glucuronidase Human genes 0.000 description 1
108010060309 Glucuronidase Proteins 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
239000007995 HEPES buffer Substances 0.000 description 1
241000168913 Haplorrhini Species 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
208000005176 Hepatitis C Diseases 0.000 description 1
241001272567 Hominoidea Species 0.000 description 1
101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 1
101100118549 Homo sapiens EGFR gene Proteins 0.000 description 1
101100121078 Homo sapiens GAL gene Proteins 0.000 description 1
101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 1
101000868440 Homo sapiens Sorting nexin-8 Proteins 0.000 description 1
101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 1
101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
101500024917 Homo sapiens Tumor necrosis factor, membrane form Proteins 0.000 description 1
241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
201000001431 Hyperuricemia Diseases 0.000 description 1
108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
108010061833 Integrases Proteins 0.000 description 1
102100025304 Integrin beta-1 Human genes 0.000 description 1
102000008070 Interferon-gamma Human genes 0.000 description 1
108010074328 Interferon-gamma Proteins 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
241000288904 Lemur Species 0.000 description 1
241000288903 Lemuridae Species 0.000 description 1
241000168911 Lemuriformes Species 0.000 description 1
241001277091 Lophocebus albigena albigena Species 0.000 description 1
241001277089 Lophocebus aterrimus Species 0.000 description 1
241000288986 Lorisidae Species 0.000 description 1
241000168918 Lorisiformes Species 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
206010025323 Lymphomas Diseases 0.000 description 1
208000012513 MVP1 Diseases 0.000 description 1
241001312962 Macaca cyclopis Species 0.000 description 1
241000293888 Macaca hecki Species 0.000 description 1
241000293893 Macaca leonina Species 0.000 description 1
241000601290 Macaca munzala Species 0.000 description 1
241000583489 Macaca pagensis Species 0.000 description 1
241001013900 Macaca siberu Species 0.000 description 1
241000532828 Macaca silenus Species 0.000 description 1
101710125418 Major capsid protein Proteins 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241000282534 Mandrillus Species 0.000 description 1
241000282532 Mandrillus leucophaeus Species 0.000 description 1
108091022912 Mannose-6-Phosphate Isomerase Proteins 0.000 description 1
102000048193 Mannose-6-phosphate isomerases Human genes 0.000 description 1
241001378568 Marcgravia umbellata Species 0.000 description 1
208000026139 Memory disease Diseases 0.000 description 1
206010027476 Metastases Diseases 0.000 description 1
101100261636 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) trpB2 gene Proteins 0.000 description 1
241000404172 Minois dryas Species 0.000 description 1
241001504671 Miopithecus Species 0.000 description 1
208000034486 Multi-organ failure Diseases 0.000 description 1
208000010718 Multiple Organ Failure Diseases 0.000 description 1
101100346932 Mus musculus Muc1 gene Proteins 0.000 description 1
208000000112 Myalgia Diseases 0.000 description 1
102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
238000005481 NMR spectroscopy Methods 0.000 description 1
241000158526 Nasalis Species 0.000 description 1
208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
102000007999 Nuclear Proteins Human genes 0.000 description 1
108010089610 Nuclear Proteins Proteins 0.000 description 1
101710141454 Nucleoprotein Proteins 0.000 description 1
240000007817 Olea europaea Species 0.000 description 1
239000012124 Opti-MEM Substances 0.000 description 1
229940122060 Ornithine decarboxylase inhibitor Drugs 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241000282576 Pan paniscus Species 0.000 description 1
241000282320 Panthera leo Species 0.000 description 1
241000250930 Penicillata Species 0.000 description 1
108010090127 Periplasmic Proteins Proteins 0.000 description 1
101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 description 1
241000550811 Piliocolobus badius badius Species 0.000 description 1
241000550813 Piliocolobus badius temminckii Species 0.000 description 1
241000277921 Piliocolobus gordonorum Species 0.000 description 1
241000277924 Piliocolobus kirkii Species 0.000 description 1
241000277922 Piliocolobus rufomitratus Species 0.000 description 1
206010035226 Plasma cell myeloma Diseases 0.000 description 1
229920002560 Polyethylene Glycol 3000 Polymers 0.000 description 1
229920002562 Polyethylene Glycol 3350 Polymers 0.000 description 1
229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 1
239000004721 Polyphenylene oxide Substances 0.000 description 1
229920001214 Polysorbate 60 Polymers 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
241001372382 Presbytis chrysomelas Species 0.000 description 1
241001312923 Presbytis comata Species 0.000 description 1
241001312925 Presbytis femoralis Species 0.000 description 1
241001372377 Presbytis frontata Species 0.000 description 1
241001372378 Presbytis hosei Species 0.000 description 1
241001312916 Presbytis melalophos Species 0.000 description 1
241001372369 Presbytis potenziani Species 0.000 description 1
241001372152 Presbytis rubicunda Species 0.000 description 1
241001372154 Presbytis thomasi Species 0.000 description 1
101710083689 Probable capsid protein Proteins 0.000 description 1
241000367426 Procolobus Species 0.000 description 1
102100024952 Protein CBFA2T1 Human genes 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
241000530385 Pygathrix Species 0.000 description 1
241000005091 Pygathrix cinerea Species 0.000 description 1
241000530389 Pygathrix nemaeus Species 0.000 description 1
208000030555 Pygmy Diseases 0.000 description 1
206010037660 Pyrexia Diseases 0.000 description 1
LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
238000011530 RNeasy Mini Kit Methods 0.000 description 1
241000931180 Rhinopithecus avunculus Species 0.000 description 1
241000881858 Rhinopithecus bieti Species 0.000 description 1
241000881856 Rhinopithecus roxellana Species 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
239000008156 Ringer's lactate solution Substances 0.000 description 1
241000714474 Rous sarcoma virus Species 0.000 description 1
101100123851 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HER1 gene Proteins 0.000 description 1
241000815718 Saguinus inustus Species 0.000 description 1
241001416140 Saguinus midas Species 0.000 description 1
241000288956 Saguinus mystax Species 0.000 description 1
241001125016 Saimiri boliviensis Species 0.000 description 1
241001223354 Saimiri oerstedii Species 0.000 description 1
241000932818 Saimiri ustus Species 0.000 description 1
241000160761 Satyrus Species 0.000 description 1
241000555745 Sciuridae Species 0.000 description 1
241000015711 Semnopithecus entellus Species 0.000 description 1
241001016068 Semnopithecus hypoleucos Species 0.000 description 1
241001016066 Semnopithecus priam Species 0.000 description 1
241000607715 Serratia marcescens Species 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
241000680159 Simias concolor Species 0.000 description 1
241001272562 Simiiformes Species 0.000 description 1
240000006394 Sorghum bicolor Species 0.000 description 1
102100032848 Sorting nexin-8 Human genes 0.000 description 1
241000168914 Strepsirrhini Species 0.000 description 1
108091027544 Subgenomic mRNA Proteins 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
230000005867 T cell response Effects 0.000 description 1
102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 1
241000288942 Tarsiidae Species 0.000 description 1
206010043376 Tetanus Diseases 0.000 description 1
241000282538 Theropithecus Species 0.000 description 1
241000256648 Trachypithecus auratus Species 0.000 description 1
241000409962 Trachypithecus barbei Species 0.000 description 1
241001154123 Trachypithecus delacouri Species 0.000 description 1
241000409963 Trachypithecus germaini Species 0.000 description 1
241001154124 Trachypithecus laotum Species 0.000 description 1
241001154119 Trachypithecus poliocephalus Species 0.000 description 1
241001311562 Trachypithecus shortridgei Species 0.000 description 1
108700019146 Transgenes Proteins 0.000 description 1
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
241001504501 Troglodytes Species 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
241000208041 Veronica Species 0.000 description 1
208000012886 Vertigo Diseases 0.000 description 1
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
210000001015 abdomen Anatomy 0.000 description 1
RRNJROHIFSLGRA-JEDNCBNOSA-N acetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.NCCCC[C@H](N)C(O)=O RRNJROHIFSLGRA-JEDNCBNOSA-N 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
230000009471 action Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
WYJWVZZCMBUPSP-KQYNXXCUSA-N adenosine 5'-(hexahydrogen pentaphosphate) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO[P@@](O)(=O)O[P@](O)(=O)O[P@@](O)(=O)O[P@@](O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O WYJWVZZCMBUPSP-KQYNXXCUSA-N 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
239000008272 agar Substances 0.000 description 1
230000001476 alcoholic effect Effects 0.000 description 1
108700025316 aldesleukin Proteins 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
230000007815 allergy Effects 0.000 description 1
230000000735 allogeneic effect Effects 0.000 description 1
230000008860 allosteric change Effects 0.000 description 1
HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
229940126575 aminoglycoside Drugs 0.000 description 1
238000012870 ammonium sulfate precipitation Methods 0.000 description 1
230000033115 angiogenesis Effects 0.000 description 1
230000000340 anti-metabolite Effects 0.000 description 1
230000000259 anti-tumor effect Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
229940100197 antimetabolite Drugs 0.000 description 1
239000002256 antimetabolite Substances 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
239000003125 aqueous solvent Substances 0.000 description 1
239000008135 aqueous vehicle Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
229960003121 arginine Drugs 0.000 description 1
206010003119 arrhythmia Diseases 0.000 description 1
210000001367 artery Anatomy 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
230000031018 biological processes and functions Effects 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 1
150000004663 bisphosphonates Chemical class 0.000 description 1
CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
238000009395 breeding Methods 0.000 description 1
230000001488 breeding effect Effects 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
ZEWYCNBZMPELPF-UHFFFAOYSA-J calcium;potassium;sodium;2-hydroxypropanoic acid;sodium;tetrachloride Chemical compound [Na].[Na+].[Cl-].[Cl-].[Cl-].[Cl-].[K+].[Ca+2].CC(O)C(O)=O ZEWYCNBZMPELPF-UHFFFAOYSA-J 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
230000000711 cancerogenic effect Effects 0.000 description 1
101150055276 ced-3 gene Proteins 0.000 description 1
239000012578 cell culture reagent Substances 0.000 description 1
230000022131 cell cycle Effects 0.000 description 1
230000011712 cell development Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
230000005859 cell recognition Effects 0.000 description 1
238000002659 cell therapy Methods 0.000 description 1
108091092328 cellular RNA Proteins 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
238000013375 chromatographic separation Methods 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
208000016350 chronic hepatitis B virus infection Diseases 0.000 description 1
208000019425 cirrhosis of liver Diseases 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
238000012761 co-transfection Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
238000004891 communication Methods 0.000 description 1
238000004590 computer program Methods 0.000 description 1
230000006552 constitutive activation Effects 0.000 description 1
239000003246 corticosteroid Substances 0.000 description 1
229960001334 corticosteroids Drugs 0.000 description 1
239000013078 crystal Substances 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
238000007822 cytometric assay Methods 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
239000000824 cytostatic agent Substances 0.000 description 1
230000001085 cytostatic effect Effects 0.000 description 1
230000007402 cytotoxic response Effects 0.000 description 1
238000013479 data entry Methods 0.000 description 1
230000034994 death Effects 0.000 description 1
231100000517 death Toxicity 0.000 description 1
230000007123 defense Effects 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
239000005549 deoxyribonucleoside Substances 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
238000006471 dimerization reaction Methods 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
208000018459 dissociative disease Diseases 0.000 description 1
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
208000002173 dizziness Diseases 0.000 description 1
239000003534 dna topoisomerase inhibitor Substances 0.000 description 1
231100000371 dose-limiting toxicity Toxicity 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
238000009509 drug development Methods 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
238000010828 elution Methods 0.000 description 1
210000002308 embryonic cell Anatomy 0.000 description 1
210000001671 embryonic stem cell Anatomy 0.000 description 1
108010087914 epidermal growth factor receptor VIII Proteins 0.000 description 1
229940082789 erbitux Drugs 0.000 description 1
239000003797 essential amino acid Substances 0.000 description 1
235000020776 essential amino acid Nutrition 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
229940093471 ethyl oleate Drugs 0.000 description 1
230000029142 excretion Effects 0.000 description 1
125000004030 farnesyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
YYJNOYZRYGDPNH-MFKUBSTISA-N fenpyroximate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1CO/N=C/C=1C(C)=NN(C)C=1OC1=CC=CC=C1 YYJNOYZRYGDPNH-MFKUBSTISA-N 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
230000008014 freezing Effects 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
210000005095 gastrointestinal system Anatomy 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000001476 gene delivery Methods 0.000 description 1
230000008570 general process Effects 0.000 description 1
238000012268 genome sequencing Methods 0.000 description 1
102000018146 globin Human genes 0.000 description 1
108060003196 globin Proteins 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
229930004094 glycosylphosphatidylinositol Natural products 0.000 description 1
239000005090 green fluorescent protein Substances 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
201000010536 head and neck cancer Diseases 0.000 description 1
208000014829 head and neck neoplasm Diseases 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
206010073071 hepatocellular carcinoma Diseases 0.000 description 1
231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
101150113423 hisD gene Proteins 0.000 description 1
230000001744 histochemical effect Effects 0.000 description 1
239000000710 homodimer Substances 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
230000037189 immune system physiology Effects 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
210000000428 immunological synapse Anatomy 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
230000036046 immunoreaction Effects 0.000 description 1
230000001506 immunosuppresive effect Effects 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
230000001861 immunosuppressant effect Effects 0.000 description 1
229940125721 immunosuppressive agent Drugs 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
239000011261 inert gas Substances 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
238000002743 insertional mutagenesis Methods 0.000 description 1
230000010354 integration Effects 0.000 description 1
229960003130 interferon gamma Drugs 0.000 description 1
238000001361 intraarterial administration Methods 0.000 description 1
210000003093 intracellular space Anatomy 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
230000009545 invasion Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 description 1
229960004768 irinotecan Drugs 0.000 description 1
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
229960000318 kanamycin Drugs 0.000 description 1
229930027917 kanamycin Natural products 0.000 description 1
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
229930182823 kanamycin A Natural products 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
238000012153 long-term therapy Methods 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
208000020816 lung neoplasm Diseases 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
229960005357 lysine acetate Drugs 0.000 description 1
238000002595 magnetic resonance imaging Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
230000003211 malignant effect Effects 0.000 description 1
238000013507 mapping Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
230000006984 memory degeneration Effects 0.000 description 1
208000023060 memory loss Diseases 0.000 description 1
230000006996 mental state Effects 0.000 description 1
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
230000009401 metastasis Effects 0.000 description 1
239000003226 mitogen Substances 0.000 description 1
230000002297 mitogenic effect Effects 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
239000000178 monomer Substances 0.000 description 1
208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
201000000050 myeloid neoplasm Diseases 0.000 description 1
230000006654 negative regulation of apoptotic process Effects 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
239000002547 new drug Substances 0.000 description 1
239000012457 nonaqueous media Substances 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
239000000346 nonvolatile oil Substances 0.000 description 1
150000003833 nucleoside derivatives Chemical class 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
229920002113 octoxynol Polymers 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
238000006384 oligomerization reaction Methods 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
238000011275 oncology therapy Methods 0.000 description 1
210000003463 organelle Anatomy 0.000 description 1
150000002895 organic esters Chemical class 0.000 description 1
239000002818 ornithine decarboxylase inhibitor Substances 0.000 description 1
230000002018 overexpression Effects 0.000 description 1
125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
230000037368 penetrate the skin Effects 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
108700010839 phage proteins Proteins 0.000 description 1
238000009520 phase I clinical trial Methods 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
230000035479 physiological effects, processes and functions Effects 0.000 description 1
238000013492 plasmid preparation Methods 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
229920000193 polymethacrylate Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
238000002600 positron emission tomography Methods 0.000 description 1
231100000683 possible toxicity Toxicity 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
229940087463 proleukin Drugs 0.000 description 1
238000000159 protein binding assay Methods 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
230000004850 protein–protein interaction Effects 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000007115 recruitment Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000008439 repair process Effects 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
239000003161 ribonuclease inhibitor Substances 0.000 description 1
239000011435 rock Substances 0.000 description 1
238000005096 rolling process Methods 0.000 description 1
231100000279 safety data Toxicity 0.000 description 1
235000002020 sage Nutrition 0.000 description 1
238000005070 sampling Methods 0.000 description 1
239000007261 sc medium Substances 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
210000004989 spleen cell Anatomy 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
206010041823 squamous cell carcinoma Diseases 0.000 description 1
239000008174 sterile solution Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
238000001847 surface plasmon resonance imaging Methods 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
231100000378 teratogenic Toxicity 0.000 description 1
230000003390 teratogenic effect Effects 0.000 description 1
238000010257 thawing Methods 0.000 description 1
229940126585 therapeutic drug Drugs 0.000 description 1
206010043554 thrombocytopenia Diseases 0.000 description 1
230000036962 time dependent Effects 0.000 description 1
230000009258 tissue cross reactivity Effects 0.000 description 1
229940044693 topoisomerase inhibitor Drugs 0.000 description 1
231100000027 toxicology Toxicity 0.000 description 1
230000005030 transcription termination Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
239000001226 triphosphate Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
101150081616 trpB gene Proteins 0.000 description 1
101150111232 trpB-1 gene Proteins 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
241000701366 unidentified nuclear polyhedrosis viruses Species 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
238000002562 urinalysis Methods 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
210000003462 vein Anatomy 0.000 description 1
231100000889 vertigo Toxicity 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
238000003260 vortexing Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
239000000811 xylitol Substances 0.000 description 1
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
229960002675 xylitol Drugs 0.000 description 1
235000010447 xylitol Nutrition 0.000 description 1